about
Hospitalization in older patients due to adverse drug reactions -the need for a prediction toolNonadherence to Medication Therapy in Haemodialysis Patients: A Systematic ReviewOutcomes in the management of atrial fibrillation: clinical trial results can apply in practiceA community-based educational intervention to improve antithrombotic drug use in atrial fibrillationAn electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trialBarriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from EthiopiaA role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.Review of management of type 2 diabetes mellitus.New antithrombotics for atrial fibrillation.Doctor and pharmacist - back to the apothecary!Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics.In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparinNon-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals.Scabies: an ancient global disease with a need for new therapies.Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory ResponsesAccuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring.Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trialSelecting nonprescription analgesics.Clinical Pathway and Monthly Feedback Improve Adherence to Antibiotic Guideline Recommendations for Community-Acquired Pneumonia.Subacute Pain as a Predictor of Long-Term Pain Following Orthopedic Surgery: An Australian Prospective 12 Month Observational Cohort StudyValproate: a simple chemical with so much to offer.The risks of warfarin use in the elderly.Effectiveness of a national approach to prescribing education for multiple disciplinesAdherence to Antiretroviral Therapy and Virologic Failure: A Meta-AnalysisThe Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.Supervised patient self-testing of warfarin therapy using an online system.Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management.Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol.Review of psychotropic medication in Tasmanian residential aged care facilities.Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities.Lasofoxifene: selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.Drug-related problems identified in post-discharge medication reviews for patients taking warfarin.The potential for intelligent decision support systems to improve the quality and consistency of medication reviews.Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management.Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?Review of computerized clinical decision support in community pharmacy.Potential use of NOACs in developing countries: pros and cons.Pharmacological management of pain in Australian Aged Care Facilities.
P50
Q26748526-7C81AC68-5ACC-40AC-91ED-8E5D6AB2F0EEQ26774337-19BAD6BF-B782-4AF7-9F4B-9A3AC22C6682Q28188553-953E3BB8-EA13-4BF4-A357-E78E2D2DF1A5Q28213965-B70ECD0D-6FA9-412B-90CB-F8E8A62DF752Q28220672-2112640D-07B0-4DE8-91AC-3F2A0624D723Q28538825-2DC88CFB-A9CF-4712-B75E-6AFCF4C4F00FQ30996878-51AB6AC6-95B0-49F2-B6DD-A058374D8A98Q33529878-09533AAC-9945-4689-B0C7-D165985E7951Q33536960-ABEFECAA-37FB-4537-891B-2A57CBF18547Q34621696-FB8A2164-CDAF-403B-83C8-951D3CEC473FQ34989669-305ACBDC-1D6E-4AD0-97FB-3D102314247AQ35147247-5B6813BD-0A7E-407E-9BFB-B34EBC7BDA0DQ35626866-85122A24-F40C-43DF-9916-3668A324258FQ35653704-2A962D90-1BB8-44D6-9F15-4A928CE134E2Q35677899-55E225C0-F3DE-4364-98FD-E22814C56059Q35719599-C56289B3-CC24-487C-A136-D87D6D08768CQ35770534-112D7577-F968-4B17-B051-9491198DD726Q35835284-15111A63-9A63-472A-9235-F2FB782E6C1AQ35951074-EBD2E809-3552-4467-9869-DCF6C9DD1165Q36015803-FAEB161F-7C7D-42AC-B38F-9A8F9D63E85FQ36084659-0A7ADACB-86DA-43E8-AA11-9B4AA454FB44Q36194907-C683BC09-6B4E-4776-A930-D48F184E98EEQ36258047-260C7B4C-7D8B-4BF3-8919-EC826ADAD100Q36446904-3BD70D16-E57B-4C52-A452-0B9B00D11CDFQ36620209-943CC5C5-C072-40F4-A519-772016E2F83BQ36822464-FA476680-001C-417F-9146-F3C20AD95AFDQ36831120-B5F5AE3D-B396-4336-B062-7AD794831B19Q37020922-CDF9A691-BDBB-4407-A3FC-48224250B3C5Q37235128-372F81AA-8FB2-4D9E-95C1-151696540FE7Q37275804-228D9B68-4BF7-4A0B-A1AA-A5406928B808Q37765664-AD056ED1-F3D3-4849-B4E3-05DA81EFDC8EQ37848884-3882A96D-E43D-4391-8195-F2B47364DBE0Q37861982-14D64A18-847B-4EBE-BCD1-9CAD958A5DE5Q37877168-C54B7AA2-605D-496F-992D-7A2F56C747A8Q37969130-CBD66C81-12A9-47C3-AAF0-7AC0C12A7540Q38084336-F0538B12-F8DA-43AA-AEFF-E67C15AEF8A8Q38175433-16736688-7DEA-4670-9944-D4C451FE4517Q38210049-63BB8402-C73C-4A4F-A64E-61191635AD0FQ38210994-43B310C4-6DDB-4772-9565-EAC6C959429DQ38220082-975C7DA7-ABD8-46E2-BCF2-6036700E5A5C
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Gregory M Peterson
@ast
Gregory M Peterson
@en
Gregory M Peterson
@es
Gregory M Peterson
@nl
Gregory M Peterson
@sl
type
label
Gregory M Peterson
@ast
Gregory M Peterson
@en
Gregory M Peterson
@es
Gregory M Peterson
@nl
Gregory M Peterson
@sl
altLabel
GM Peterson
@en
Gregory Mark Peterson
@en
Peterson GM
@en
prefLabel
Gregory M Peterson
@ast
Gregory M Peterson
@en
Gregory M Peterson
@es
Gregory M Peterson
@nl
Gregory M Peterson
@sl
P214
P244
P106
P21
P213
0000 0000 4014 6232
P214
P244
n2008180897
P31
P496
0000-0002-6764-3882
P734
P735
P7859
lccn-n2008180897